10 Aug, 2022 08:32 AM
IVE Group Limited (IVE, ASX:IGL) announces entry into an implementation deed (Implementation Deed) with Ovato Limited (Administrators Appointed) (Ovato) and the Ovato Administrators (defined below) ...read more
28 Jul, 2022 10:07 AM
-- Phase II TACTI-002 trial met its primary objective in 1st line non-small cell lung cancer (NSCLC) patients, with 38.6% Overall Response Rate and favourable anti-tumour activity
-- Biomarker and ...read more
26 Jul, 2022 08:16 AM
ImpediMed Limited (ASX:IPD) (ImpediMed, Company) announced today that Managing Director and Chief Executive Officer (CEO) Richard Carreon would be stepping down from the Company effective close of b...read more
22 Jul, 2022 09:00 AM
Highlights
-- US Patent No 11,391,738 granted covering the hTERT technology
-- Provides further IP protection for hTERT in the USA for cancer applications beyond bladder cancer
Melbourne,&nbs...read more
11 Jul, 2022 08:25 AM
ImpediMed Limited (ASX:IPD) (ImpediMed) is pleased to announce the publication of a paper on the risk factors for breast cancer related lymphoedema. The paper was published in Cancer, an internation...read more